I clearly believe that the right way to achieve a Nasdaq listing is to grow the stock price by revealing what the company has planned for the future. Trials they're planning in the next year or so should be in the clinical trials database and they should be open about what they're doing to gain the patents they've submitted. I could see a reverse split if they brought the share price above $1 and said we'd like to boost the price to perhaps $2 to $3 in the belief that if they got it that far now, within a year they'd meet the $4 required by the Nasdaq, but the key is being over $1 before they started.
The company's proposal isn't fixed, perhaps they put it out there to see how investors would react, hopefully by now they know it's not being supported by many, it just doesn't make sense to current investors when they take the total O/S to under 1 million share. Does anyone believe that 6 months to a year later the O/S won't be 50 million shares or more. Current investors who don't add shares will end up with 1% or less of their prior percentage in the company in practically no time, even if eventually they recover their original investment.
I hope the meeting planned later this week express our dissatisfaction with what they're proposing, as was mentioned by another, I didn't push this because when I've done it myself I failed to learn much that I didn't already know, but I wasn't facing the kind of news we got this week. I don't know that the corporation will change its mind, but at least we'll be heard. As for the arguement that getting on the Nasdaq is a major achievement, it's true if you grow the company, but I don't believe it's very respected if it's achieved purely by a massive reverse split. More importantly, without building respect for the company, no stock price will hold while dilution is excessive.
Don't get me wrong, I believe there could be great future profits from bringing cannabis based products through clinical trials and to drug approvals, but I believe the way to do it is by letting the world know what you're doing.
Gary
The company's proposal isn't fixed, perhaps they put it out there to see how investors would react, hopefully by now they know it's not being supported by many, it just doesn't make sense to current investors when they take the total O/S to under 1 million share. Does anyone believe that 6 months to a year later the O/S won't be 50 million shares or more. Current investors who don't add shares will end up with 1% or less of their prior percentage in the company in practically no time, even if eventually they recover their original investment.
I hope the meeting planned later this week express our dissatisfaction with what they're proposing, as was mentioned by another, I didn't push this because when I've done it myself I failed to learn much that I didn't already know, but I wasn't facing the kind of news we got this week. I don't know that the corporation will change its mind, but at least we'll be heard. As for the arguement that getting on the Nasdaq is a major achievement, it's true if you grow the company, but I don't believe it's very respected if it's achieved purely by a massive reverse split. More importantly, without building respect for the company, no stock price will hold while dilution is excessive.
Don't get me wrong, I believe there could be great future profits from bringing cannabis based products through clinical trials and to drug approvals, but I believe the way to do it is by letting the world know what you're doing.
Gary
1
